Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain
CompletedNot applicableNCT02824588
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this project is to investigate and improve executive control function in two distinct pain conditions, namely neuropathic pain and fibromyalgia (FM). It is hypothesized that there is a significant difference in the executive control function of patients with neuropathic pain and FM pain. It is also hypothesized that all participants with poor executive control functioning will report significant improvements in pain intensity, functioning and cognitive complaints following cognitive training. The study tests and influence the working memory concepts of inhibition, updating and flexibility through an experimental, cross-over treatment design. To perform the experiment, we will recruit 160 participants (80 with neuropathic pain and 80 with FM) from the Departments of pain management and research at St Olav's University Hospital and Oslo University Hospital (OUS). The proposed design will be able to determine whether or not executive control, processing speed and memory function differs in two distinct populations of pain patients. Moreover, whether impairments are amended by computerized training.
Study details
- Official title
- Executive Control, Processing Speed and Memory Function in Long- Term Peripheral Neuropathic Pain and Fibromyalgia
- Conditions
- Working Memory Deficits
- Neuropathic Pain
- Fibromyalgia
- Interventions
- Behavioral: Working Memory Training
- Behavioral: Internet use
- Sponsor
- Oslo University Hospital
- Start date
- 2016-09
- Primary completion
- 2018-09-02
- Sex
- All
- Age range
- from 18 Years to 69 Years
- Results posted
- No results posted in this snapshot
- Countries
- Norway
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Confirmed diagnosis of fibromyalgia or neuropathic pain * Confirmed objective cognitive impairments on the CANTAB battery compared to IQ control Exclusion Criteria: * Mania, suicidal ideation and/or active psychosis * No objective cognitive impairments * Personality disorders * Pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02824588